|
Obese Patients with Type 2 Diabetes Clinical Trials Information presented on Clinical Trials Search isn't intended to be a substitute for proven healthcare advice, trips or treatment using a real physician. We are not docs. Always confer with your mD on Obese Patients with Type 2 Diabetes conditions. Clinical Trials Search.org is a site dedicated to listing clinical research studies in human subjects. Obese Patients with Type 2 Diabetes Clinical research trials and Obese Patients with Type 2 Diabetes medical trials take place in hundreds of localities across the U.S.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually measure the effectiveness of new drugs. The intention of the studies / projects is to resolve certain human health questions. Clinical trials are a popular means for physicians, government agencies, and private sector corporations to detect remedies for all forms of circumstances, like Obese Patients with Type 2 Diabetes. Obese Patients with Type 2 Diabetes Clinical Trials and other clinical trials allow for volunteers to undergo healthcare treatment options before they are available to the masses. Most times the participants receive treatment for free, and every now and again they are paid for their time. Occasionally there is a cost for a Obese Patients with Type 2 Diabetes clinical trial. Subjects typically recieve the finest healthcare available for their Obese Patients with Type 2 Diabetes condition. Hazards are a reality, nonetheless, and might include more or frequent mD trips, health risks (potentially life-endangering), and/or the treatment being ineffective. Trials are federally regulated with stern guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "O" Clinical Trials Conditions > Obese Patients with Type 2 Diabetes Obese Patients with Type 2 Diabetes
Obese Patients with Type 2 Diabetes
For Condition: Obesity,Obesity in Diabetes,Diabetes Mellitus, Non-Insulin-Dependent
Status: Completed
Sponsor(s): Sanofi-Synthelabo ,
Synopsis: To assess the effect on weight loss and weight maintenance over a period of one year when prescribed with a hypocaloric diet in obese patients with Type 2 Diabetes
Details:
Eligibility:
Study Type: Interventional, Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study
Minimum Age/Maximum Age: 18 Years/70 Years
Genders: Both
Protocol Entry Criteria: - BMI must be greater than 27 and less than 40 - Treated Type 2 Diabetes on single therapy treatment for at least 1 year - Stable weight (variation of less than 5 kg within 3 months prior to screening visit)
Total Enrollment: 370
Location and Contact Information:
Jacksonville Center for Clinical Research
Jacksonville, Florida, 32216
United States
Innovative Clinical Trials
Birmingham, Alabama, 35209
United States
nTouch Research
Marietta, Georgia, 30066
United States
North East Clinical Research
Hamden, Connecticut, 06518
United States
Jackson Downey, MD
Jacksonville, Florida, 32205
United States
Salem Veterans Affairs Medical Center (151)
Salem, Virginia, 24153
United States
Endocrinology and Diabetes Consultants, PC
Dover, New Hampshire, 03820
United States
Physician Clinical Research Service
White Plains, New York, 10605
United States
DMI Helathcare Group
Largo, Florida, 33773
United States
Radiant Research
Cincinnati, Ohio, 45236
United States
Diablo Clinical Research, Inc.
Walnut Creek, California, 94598
United States
MFP Research, Inc.
Cincinnati, Ohio, 45242
United States
Kansas University Medical Center
Kansas City, Kansas, 66160
United States
Medical University of South Carolina, Division of Clinical Pharmacology
Charleston, South Carolina, 29425
United States
Anderson Clinical Research
San Bernardino, California, 92408
United States
Radiant Research
Portland, Oregon, 97201
United States
Comprehensive NeuroScience, Inc.
Sarasota, Florida, 34232
United States
Jacksonville Center for Clinical Research
Jacksonville, Florida, 32205
United States
Endocrine and Diabetes
Ogden, Utah, 84403
United States
Diabetes $ Glandular Disease Clinic, PA
San Antonio, Texas, 78229-4810
United States
Gulf States Clinical Trails, LLC
Kenner, Louisiana, 70062
United States
Center for Nutrition and Preventive Medicine
Charlotte, North Carolina, 28207
United States
The Chase Wellness Center, Inc.
Virginia Beach, Virginia, 23455
United States
Orlando Clinical Research Center
Orlando, Florida, 32806
United States
JM Clinical Trials, Inc.
Swansea, Massachusetts, 02777
United States
Lovelace Scientific Resources
Phoenix, Arizona, 85016
United States
CSRA Partners in Health, Inc.
Augusta, Georgia, 30909
United States
Phase III Clinical Research
Fall River, Massachusetts, 02720
United States
MediSphere Medical Research Center, LLC
Evansville, Indiana, 47714
United States
Twin Cities Clinical Research
Arden Hills, Minnesota, 55126
United States
Advanced Clinicla Therapeutics, LLC
Tucson, Arizona, 85712
United States
Metabolic Research Institute
West Palm Beach, Florida, 33401
United States
National Clinical Research
Richmond, Virginia, 23294
United States
Costal Carolina Research Center
Mt. Pleasant, South Carolina, 29464
United States
Clinical Research of South Florida
Coral Gables, Florida, 33134
United States
University Clinical Research
Pembroke Pines, Florida, 33024
United States
University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma, 73104
United States
TriCities Medical Reseach
Bristol, Tennessee, 37620
United States
Physicians Research Group
Indianapolis, Indiana, 46250
United States
Medical Research Institute
Slidell, Louisiana, 70458
United States
Radiant Reseach-Moorestown
Moorestown, New Jersey, 08057
United States
Lovelace Scientific Resources
Las Vegas, Nevada, 89014
United States
Southern California Prevention and Research Center Inc. (SPARC)
Encino, California, 91436
United States
Lovelace Scientific Resources
Albuquerque, New Mexico, 87108
United States
Androscoggin Cardiology Associates
Auburn, Maine,
United States
Additional Information:
Study ID Numbers: EFC4736; SR141716
Study Start Date: September 2001
Record last reviewed: May 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00029848
Other Obesity Studies:
1. Diabetes Prevention Program
2. Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus Treated With a Sulfonylurea
3. Identification and therapy efficacy of Type 2 diabetes in Hispanic patients
4. A Research Study to determine the safety and efficacy of Glucovance Compared to Metformin and Glyburide in Children and Adolescents with Type 2 Diabetes.
5. The ORIGIN Trial (Outcome Reduction with Initial Glargine Intervention)
Related Studies:
Other Obesity Clinical Trials
Other California Clinical Trials
Other San Bernardino Clinical Trials
Obese Patients with Type 2 Diabetes
|
|
|
|
|
|
|
|